| Sabrina Baisdon, | |
|
1752 E Bullard Ave Ste 101, Fresno, CA 93710-5864 | |
| (559) 970-8277 | |
| Not Available |
| Full Name | Sabrina Baisdon |
|---|---|
| Gender | Female |
| Speciality | Speech-language Pathologist |
| Location | 1752 E Bullard Ave Ste 101, Fresno, California |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1003545344 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 235Z00000X | Speech-language Pathologist | (* (Not Available)) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Sabrina Baisdon, 2743 Commonwood Ln, Clovis, CA 93619-7954 Ph: (209) 225-0005 | Sabrina Baisdon, 1752 E Bullard Ave Ste 101, Fresno, CA 93710-5864 Ph: (559) 970-8277 |
News Archive
This Thursday, July 8, 2010, the Academy of General Dentistry and the AGD Foundation will team up with the Louisiana State University School of Dentistry to hold its first outreach project, Nation of Smiles, One Smile at a Time. This event will provide upwards of 300 patients from local shelters, clinics and charities with free dental care from volunteer dentists, hygienists, and dental assistants from around the nation. LSU dental students also will be participating.
A model that predicts outbreaks of zoonotic diseases - those originating in livestock or wildlife such as Ebola and Zika - based on changes in climate, population growth and land use has been developed by a UCL-led team of researchers.
Destinations in nature, such as a lakeside or a walking trail, are the most commonly perceived environmental features motivating older adults to engage in outdoor mobility.
Janssen Research & Development, LLC today announced the submission of a New Drug Application (NDA) for three-month atypical antipsychotic paliperidone palmitate to the U.S. Food and Drug Administration. The NDA seeks approval for the medication as a treatment for schizophrenia in adults.
Santarus, Inc. and Depomed, Inc. today announced that they have entered into a new commercialization agreement for GLUMETZA (metformin hydrochloride extended release tablets) under which Santarus will assume broad commercial, manufacturing and regulatory responsibilities to replace a promotion agreement that the companies entered into in July 2008.
› Verified 6 days ago
Tenaya Latrice Yarbrough-maxwell, M.A.-CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 4602 W Oslin Ave, Fresno, CA 93722 Phone: 559-761-3813 | |
Mrs. Jodi Megumi Alatorre, M.A.CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1351 E Spruce Ave, Fresno, CA 93720 Phone: 559-432-3303 | |
Shannon Johnson, M.A., CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 2505 W Shaw Ave Bldg A, Fresno, CA 93711 Phone: 559-228-9100 Fax: 559-228-9200 | |
Ms. Tracy D. Carroll, MA CCC SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 5100 N 6th St, Suite 115a, Fresno, CA 93710 Phone: 559-978-0701 Fax: 559-324-0541 | |
Elsa Maria Castillo, M.A., CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 2615 E Clinton Ave, Fresno, CA 93703 Phone: 559-225-6100 | |
Simpson Speech And Language Therapy Services, Pc Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 2405 Tulare St Ste 200, Fresno, CA 93721 Phone: 559-797-1873 Fax: 559-472-3076 |